Ilse Van Vlaenderen - Search Results

Year	Number of Results
2011	1
2012	2
2013	3
2014	1
2015	1
2016	1
2017	1
2018	1
2019	2
2020	2
2021	2
2022	1
2023	2
2024	0

1

Do High Levels of Maternally Derived Antibodies Interfere with the Vaccination of Piglets against Porcine Circovirus Type 2? A Literature Review and Data Analysis.

Poulsen Nautrup B, Van Vlaenderen I, Mah C, Angulo J. Poulsen Nautrup B, et al. Among authors: van vlaenderen i. Vaccines (Basel). 2021 Aug 19;9(8):923. doi: 10.3390/vaccines9080923. Vaccines (Basel). 2021. PMID: 34452048 Free PMC article. Review.

2

Constrained Optimization for Pneumococcal Vaccination in Brazil.

Olbrecht J, Gomez JA, Van Bellinghen LA, Van Vlaenderen I, Standaert B. Olbrecht J, et al. Among authors: van vlaenderen i. Value Health Reg Issues. 2021 Dec;26:40-49. doi: 10.1016/j.vhri.2020.11.011. Epub 2021 Apr 10. Value Health Reg Issues. 2021. PMID: 33848895 Free article.

3

A Chimeric Vaccine against Porcine Circovirus Type 2: Meta-Analysis of Comparative Clinical Trials.

Poulsen Nautrup B, Van Vlaenderen I, Mellencamp MA. Poulsen Nautrup B, et al. Among authors: van vlaenderen i. Vaccines (Basel). 2023 Mar 3;11(3):584. doi: 10.3390/vaccines11030584. Vaccines (Basel). 2023. PMID: 36992168 Free PMC article.

4

Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico.

Gomez J, Velázquez FR, Guzman-Holst A, Cervantes Apolinar MY, Van Bellinghen LA, Van Vlaenderen I, van Oorschot D. Gomez J, et al. Among authors: van vlaenderen i. Hum Vaccin Immunother. 2023 Aug 1;19(2):2219189. doi: 10.1080/21645515.2023.2219189. Epub 2023 Jun 20. Hum Vaccin Immunother. 2023. PMID: 37339232 Free PMC article.

5

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project.

Standaert B, Van Vlaenderen I, Van Bellinghen LA, Talbird S, Hicks K, Carrico J, Buck PO. Standaert B, et al. Among authors: van vlaenderen i. Appl Health Econ Health Policy. 2020 Aug;18(4):519-531. doi: 10.1007/s40258-019-00534-y. Appl Health Econ Health Policy. 2020. PMID: 31755016 Free PMC article.

6

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.

Molnar D, Anastassopoulou A, Poulsen Nautrup B, Schmidt-Ott R, Eichner M, Schwehm M, Dos Santos G, Ultsch B, Bekkat-Berkani R, von Krempelhuber A, Van Vlaenderen I, Van Bellinghen LA. Molnar D, et al. Among authors: van vlaenderen i. Hum Vaccin Immunother. 2022 Nov 30;18(5):2058304. doi: 10.1080/21645515.2022.2058304. Epub 2022 Apr 29. Hum Vaccin Immunother. 2022. PMID: 35486410 Free PMC article.

7

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries.

Sauboin C, Van Bellinghen LA, Van De Velde N, Van Vlaenderen I. Sauboin C, et al. Among authors: van vlaenderen i. MDM Policy Pract. 2019 Dec 10;4(2):2381468319873324. doi: 10.1177/2381468319873324. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31853505 Free PMC article.

8

Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study.

Sauboin CJ, Van Bellinghen LA, Van De Velde N, Van Vlaenderen I. Sauboin CJ, et al. Among authors: van vlaenderen i. Malar J. 2015 Dec 23;14:524. doi: 10.1186/s12936-015-1046-z. Malar J. 2015. PMID: 26702637 Free PMC article. Clinical Trial.

9

Reducing Malaria Mortality at the Lowest Budget: An Optimization Tool for Selecting Malaria Preventative Interventions Applied to Ghana.

Sauboin C, Van Vlaenderen I, Van Bellinghen LA, Standaert B. Sauboin C, et al. Among authors: van vlaenderen i. MDM Policy Pract. 2019 Jul 25;4(2):2381468319861346. doi: 10.1177/2381468319861346. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31384668 Free PMC article.

10

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.

Dolk C, Eichner M, Welte R, Anastassopoulou A, Van Bellinghen LA, Poulsen Nautrup B, Van Vlaenderen I, Schmidt-Ott R, Schwehm M, Postma M. Dolk C, et al. Among authors: van vlaenderen i. Pharmacoeconomics. 2016 Dec;34(12):1299-1308. doi: 10.1007/s40273-016-0443-7. Pharmacoeconomics. 2016. PMID: 27647004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year